Download presentation
1
Neurotoxicity in Occupational Health
Diploma in Occupational Health UCT Nov 2005 You are free: to Share – to copy, distribute and transmit the work to Remix – to adapt the work Under the following conditions: Attribution. You must attribute the work in the manner specified by the author or licensor (but not in any way that suggests that they endorse you or your use of the work) Non-commercial. You may not use this work for commercial purposes. Share Alike. If you alter, transform, or build upon this work, you may distribute the resulting work but only under the same or similar license to this one. • For any reuse or distribution, you must make clear to others the license terms of this work. One way to do this is with a link to the license web page: • Any of the above conditions can be waived if you get permission from the copyright holder. • Nothing in this license impairs or restricts the authors’ moral rights. • Nothing in this license impairs or restricts the rights of authors whose work is referenced in this document. • Cited works used in this document must be cited following usual academic conventions • Citation of this work must follow normal academic conventions Source work at Vula. Permissions beyond the scope of this license may be available at or contact Leslie London, University of Cape Town
2
Leslie London, University of Cape Town
This work is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 2.5 South Africa License. Under the following conditions: Attribution. You must attribute the work in the manner specified by the author or licensor (but not in any way that suggests that they endorse you or your use of the work) Non-commercial. You may not use this work for commercial purposes. Share Alike. If you alter, transform, or build upon this work, you may distribute the resulting work but only under the same or similar license to this one. • For any reuse or distribution, you must make clear to others the license terms of this work. One way to do this is with a link to the license web page: • Any of the above conditions can be waived if you get permission from the copyright holder. • Nothing in this license impairs or restricts the authors’ moral rights. • Nothing in this license impairs or restricts the rights of authors whose work is referenced in this document. • Cited works used in this document must be cited following usual academic conventions • Citation of this work must follow normal academic conventions Source work at Vula. Permissions beyond the scope of this license may be available at or contact Leslie London, University of Cape Town
3
Neurotoxicity Definition: “Neurotoxicity refers to the capability of inducing adverse effects in the central nervous system, peripheral nerves or sensory organs. A chemical is considered to be neurotoxic if it is capable of inducing a consistent pattern of neural dysfunction or change in the chemistry or structure of the nervous system.” International Labour Organisation, 2003 Note – can also have CNS effects of trauma, asphyxia, etc Leslie London, University of Cape Town
4
Historical Perspective
Drug-induced neurotoxicity Occupational toxins Main categories: metals solvents pesticides > chemicals in use, 2000 new chemicals / year; yet minority tested for neurotoxicity (+/- 800 recognised ntoxins) Leslie London, University of Cape Town
5
Consequence of toxin exposure for the nervous system:
changes in sensory input (loss of vision, hearing, smell, etc) hinder the capacity to control movement and body functions affect brain’s capacity to manage information behavioural or psychological disorders (mood and personality changes) Leslie London, University of Cape Town
6
Why is the Nervous System uniquely sustainable to toxicity?
limited capacity for repair complex functional organisation sensitive to other organ malfunction Leslie London, University of Cape Town
7
Neurotoxic syndromes Peripheral neuropathy Encephalopathy
Bulbar or spinal cord syndromes Extrapyramidal Psychiatric Neuropsychological Tremor Neuro-endocrine Leslie London, University of Cape Town
8
Exposures and effects Varied, ubiquitous exposures - Beware fixed expectations of job exposures Mechanisms wide ranging: e.g. target cell processes in membrane transport, internal cellular chemical reactions, liberation of secretory substances, etc. Specific vs Non-Specific effects E.g. autonomic PN due to dimethylaminoproprionitrile e.g. purely motor neuropathy (lead, TOCP) Neurotoxicity manifested as continuum of symptoms and effects depend on the nature of the chemical, dose, duration of exposure and individual traits Leslie London, University of Cape Town
9
Hallmark is axonal damage
Central and peripheral Typically symmetrical sensory-motor polyneuropathy (autonomic, demyelination, etc rare) NB! NB! Exposures are usually to cocktails of chemicals – rarely to single chemical Leslie London, University of Cape Town
10
Early symptoms of chronic poisoning
Altered mood states: Irritability, euphoria, sudden mood changes, excessive tiredness, feelings of hostility, anxiousness, depression and tension Cognitive: memory problems, concentration difficulties Other: drunkenness, dizziness, slowness, tingling sensation in hands or feet, loss of libido Symptoms are non-specific, usually do not interfere with work ignored, or attributed to non-occupational cause Hence NB to have high index of awareness Leslie London, University of Cape Town
11
Early motor, sensory and cognitive changes
manual dexterity, grip strength motor speed, hand steadiness, Vocabulary colour vision, vibrotactile perception Hearing, smell With increasing exposure, changes in: Reaction time hand-eye coordination short-term memory visual and auditory memory attention and vigilance Leslie London, University of Cape Town
12
Severity levels (Simonsen et al, 1994)
Grouping Explanation 6 Morphological Cell death, axonopathy, and s/clinical 5 Neurological Abn findings on examination 4 Physiological / behavioural Experimental findings in groups: EEG, evoked potentials, neuropsych tests 3 Biochemical Neurotransmitters, proteins 2 Irreversible symptoms Subjective symptoms. No abn on exam / tests 1 Reversible symptoms Leslie London, University of Cape Town
13
Biomonitoring Metals often stored in bone
Blood or urine concentrations may reflect body burden = basis for biological monitoring (bone fluoroscopy for Pb) Release from storage sites may be very slow (e.g. Pb burden 50% over 10 years. (Can be accelerated with chelating agents = treatment) Leslie London, University of Cape Town
14
Clinical vs Sub clinical effects
Histologic Electrophysiological Clinical – Sign – Symptoms Subclinical Sensory Testing vibration sense (esp long nerves in feet) colour vision postural sway Neurobehavioural: Cognitive domains etc (Population shifts, accelerated aging, compensatory capacity, etc) Leslie London, University of Cape Town
15
Peripheral Neuropathy
Metals: Arsenic, Thallium, Lead, Org Mercury Gases: Ethylene Oxide, MethylBromide Grouting Agents: Acrylamide, Dimethylacryloprioprionitrite (DMAP) Industrial Solvents: n-hexane, methyl-n-butyl-ketone, CS2, trichlorethylene, methanol Pesticides: Organophosphates, Organochlorines, organotins, Pb arsenate NB all have different mechanisms! Leslie London, University of Cape Town
16
Encephalopathy Global cerebral impairment: Cerebellar: Parkinsoniasm:
Solvents, Heavy metals, CS2 Cerebellar: toluene, mercury Parkinsoniasm: manganese, CO, CS2 Opsoclonus: kepone Leslie London, University of Cape Town
17
Metal Neurotoxicity Heavier the metal, more toxic (Pb, Hg)
Environmental risks NB (e.g. in water) Bioaccumulate if organic form food chain Routes absorption: pure metal: inhalation or skin contact (e.g. Hg) Inorganic metal: oral Organic metal: inhalation or skin contact Leslie London, University of Cape Town
18
NEUROTOXICITY OF CHEMICALS
EXPOSURE – EFFECT RELATIONSHIPS What sort of Exposure? What sort of Effect? ACUTE INTOXICATION ACUTE EFFECTS EPISODIC Reversible LONG-TERM LOW DOSE CHRONIC EFFECTS Irreversible ? SPECTRUM Progression SPECTRUM ? ? Leslie London, University of Cape Town
19
Implications of the Continuum of effects
Early alterations in groups of exposed workers using sensitive measures of impairment can be used to prompt preventive actions. In later stages, a good clinical knowledge is required and differential diagnosis is essential to the adequate treatment and care of disabled workers Leslie London, University of Cape Town
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.